Drug Profile
CTX 3397
Alternative Names: CTX-3397Latest Information Update: 13 Sep 2023
Price :
$50
*
At a glance
- Originator Celtaxsys
- Class Anti-inflammatories; Neuroprotectants
- Mechanism of Action Leukotriene A4 hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Multiple sclerosis